Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
mesenchymal stem cells (Hospital de Clinicas de Porto Alegre)
- Development stage
- Unknown
- Lead developer
- Hospital de Clínicas de Porto Alegre
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
Bone marrow-derived mesenchymal stem cells (MSCs) from the Hospital de Clinicas de Porto Alegre are an investigational cell therapy designed to treat steroid-resistant acute graft-versus-host disease (aGVHD). These cells are isolated from bone marrow and expanded ex vivo under Good Manufacturing Practice (GMP) conditions. MSCs function as potent immunomodulators; they migrate to sites of inflammation and interact with various immune cells to suppress the overactive immune response seen in aGVHD. Their mechanism of action includes the inhibition of alloreactive T-cell proliferation and the induction of regulatory T-cells (Tregs), which helps restore immune homeostasis. This therapy is typically administered via intravenous infusion to patients who have failed first-line corticosteroid treatment.
- Other names
- mesenchymal stem cells-Hospital de Clinicas de Porto Alegre-acute graft versus host diseasehuman mesenchymal stem cellsMSCsmesenchymal stromal cells
Beyond the preview
Go deeper on mesenchymal stem cells (Hospital de Clinicas de Porto Alegre).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on mesenchymal stem cells (Hospital de Clinicas de Porto Alegre).